Mariah Stein, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-360-5550 |
Serc - Atchison Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 415 S 10th St, Atchison, KS 66002 Phone: 913-370-9501 Fax: 913-367-5061 |
Amy Andrews, PT Physical Therapist - Geriatrics Medicare: Medicare Enrolled Practice Location: 801 S 8th St, Atchison, KS 66002 Phone: 913-360-6200 |
Ronald W Wagner, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 415 S 10th St, Atchison, KS 66002 Phone: 913-370-9500 Fax: 913-367-5061 |
Cory Eckert Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1419 N 6th St, Atchison, KS 66002 Phone: 913-367-1905 |
Amy J Hackmann, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 S 8th St, Atchison, KS 66002 Phone: 913-637-6110 |
Mrs. Michele Renee Combs Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-360-5550 |
Mariah Kathryn Henning, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-360-5550 |
Tyler Mitchell Deutscher, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 415 S 10th St, Atchison, KS 66002 Phone: 913-370-9501 Fax: 913-937-9423 |
Dr. Adam Ryan Goodpasture, DPT, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-360-5550 Fax: 913-674-2015 |
News Archive
There are distinct gender differences underlying the risks for abuse of prescription pain drugs, according to a Harvard study published in The Journal of Pain, the peer review journal of the American Pain Society, www.ampainsoc.org and www.jpain.org.
Three scientists from Keck Medicine of the University of Southern California have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine for research that includes creating a temporary liver for transplant patients, finding novel ways to treat immune disorders and blood diseases and developing a new animal model for exploring diseases like heart failure, diabetes and neurodegenerative diseases.
The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.
News outlets report on deals struck with individual senators, in particular Sen. Ben Nelson, D-Neb., in an effort to win support for health care legislation.
› Verified 6 days ago